Prescription drug · NDA
Desferal (Deferoxamine mesylate) NDC 87081-467
Deferoxamine mesylate 500 mg/5mL · Injection, Powder, For solution · Intravenous, Subcutaneous · MITEM PHARMA
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 87081-467-91 | 87081046791 | 4 mL in 1 VIAL (87081-467-91)Marketed from Apr 2, 1968 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Desferal
- Generic name (nonproprietary)
- deferoxamine mesylate
- Active ingredients
- Deferoxamine mesylate — 500 mg/5mL
- Dosage form
- Injection, Powder, For solution
- Route
- Intravenous, Subcutaneous
- Labeler
- MITEM PHARMANDC labeler code 87081
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 016267
- Marketing start
- Listing expires
- Other FDA classes
- Iron Chelating Activity (Mechanism)
- Identifiers
- Product ID 87081-467_38eff751-96c6-c48a-e063-6294a90a0e48SPL ID 38eff751-96c6-c48a-e063-6294a90a0e48SPL set ID 38eff751-96c5-c48a-e063-6294a90a0e48RxCUI 1731350, 1731352UNII V9TKO7EO6K
- Pharmacologic class
- Iron Chelator
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N487081046791followed by a unit qualifier and the quantityPackage 87081-0467-91. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
About NDC 87081-467
- What is NDC 87081-467?
- 87081-467 is the product NDC for Desferal (deferoxamine mesylate), Deferoxamine mesylate 500 mg/5mL injection, powder, for solution, listed with the FDA by MITEM PHARMA. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Desferal (Deferoxamine mesylate).
- What is the active ingredient?
- Deferoxamine mesylate.
- Who is the labeler?
- MITEM PHARMA, NDC labeler code 87081. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Desferal?
- 1 other product NDC are listed under this name. See all Desferal NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Desferal products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Desferaldeferoxamine mesylate | Deferoxamine mesylate 500 mg/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous, Subcutaneous | Novartis Pharmaceuticals Corporation | 0078-0467 | 00078-0467-91 |
Other NDCs under NDA 016267
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Desferaldeferoxamine mesylate | Deferoxamine mesylate 500 mg/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous, Subcutaneous | Novartis Pharmaceuticals Corporation | 0078-0467 |